Universitätsklinikum Hamburg-Eppendorf (UKE)

Defining benchmark outcomes for mesial temporal lobe epilepsy surgery: A global multicenter analysis of 1119 cases (2024) Drexler R, Ricklefs FL, Ben-Haim S, Rada A, Wörmann F, Cloppenborg T, Bien CG, et al. Journal article Editorial: Tumor and immune cell interactions in the formation of organ-specific metastasis (2024) Gewalt T, Diehl L, Meder L Journal article Removing outliers from the normative database improves regional atrophy detection in single-subject voxel-based morphometry (2024) Schultz V, Hedderich DM, Schmitz-Koep B, Schinz D, Zimmer C, Yakushev I, Apostolova I, et al. Journal article 5qSMA: standardised retrospective natural history assessment in 268 patients with four copies of SMN2 (2024) Vill K, Tacke M, König A, Baumann M, Baumgartner M, Steinbach M, Bernert G, et al. Journal article A Day 14 Endpoint for Acute GVHD Clinical Trials (2024) Spyrou N, Akahoshi Y, Kowalyk S, Morales G, Beheshti R, Aguayo-Hiraldo P, Al Malki MM, et al. Journal article Urinary peptidomic liquid biopsy for non-invasive differential diagnosis of chronic kidney disease. (2024) Mavrogeorgis E, He T, Mischak H, Latosinska A, Vlahou A, Schanstra JP, Catanese L, et al. Journal article Survey on the working, training, and research conditions of resident physicians in internistic and rheumatological continuing education-BEWUSST. (2024) Proft F, Vossen D, Baraliakos X, Berliner MN, Fleck M, Keyßer G, Krause A, et al. Journal article Survival in primary hemophagocytic lymphohistiocytosis, 2016 to 2021: etoposide is better than its reputation (2024) Böhm S, Wustrau K, Pachlopnik Schmid J, Prader S, Ahlmann M, Yacobovich J, Beier R, et al. Journal article Finding a balance in reduced toxicity hematopoietic stem cell transplantation for thalassemia: role of infused CD3+ cell count and immunosuppression (2024) Meissner B, Lang P, Bader P, Hoenig M, Müller I, Meisel R, Greil J, et al. Journal article Update on the diagnosis and treatment of neuromyelitis optica spectrum disorders (NMOSD) - revised recommendations of the Neuromyelitis Optica Study Group (NEMOS). Part II: Attack therapy and long-term management. (2024) Kümpfel T, Giglhuber K, Aktas O, Ayzenberg I, Bellmann-Strobl J, Häußler V, Havla J, et al. Journal article, Review article